Clinical Trial Update: Role of Metabolites in Nicotine Dependence (2) - 5 [Phase 2]

View source ↗

Summary

This update documents the completion of a Phase 2 clinical trial investigating the role of metabolites in nicotine dependence for tobacco use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED